Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Anterior chamber angle granuloma: A rare ocular manifestation of histoid lepromatous leprosy

Karkhur S, Soni D, Sharma B. Medknow. Indian Journal of Ophthalmology. 2020; 68 (9) : 2031.
Download PDF
Publication

Polymorphisms of the Toll-Like Receptor-2 Gene in Patients with Leprosy and Their Healthy Contacts

Lima LNGC, Moura LS, Letícia Pinto Paz J, et al. Scientific Research Publishing, Inc.. Open Journal of Immunology. 2020; 10 (03) : 37-46.
Download PDF
Publication

EVOLUÇÃO TEMPORAL DOS CASOS NOVOS DE HANSENÍASE NO MUNICÍPIO DE PETROLINAPE, 2005 A 2014

Vasconcelos FRDS, Parente AS, Galindo ARSDL, et al. Atena Editora. Alicerces e Adversidades das Ciências da Saúde no Brasil 5. 2019;
Download PDF
Publication

Ganglionitis and myelitis: myriad neurological manifestations of Hansen's disease.

Bafna P, Sahoo R, Manoj M, et al. BMJ case reports. 2020;
Download PDF
Publication

Multibacillary Leprosy Presenting as Anetoderma in a Young Teenager.

Parajuli N, Shrestha S, Lama L, et al. Case reports in dermatological medicine. 2020;
Download PDF
Publication

Trends of the leprosy control indicators in Benin from 2006 to 2018.

Gnimavo R, Djossou P, Sopoh GE, et al. BMC public health. 2020; 20 (1) : 1254.
Download PDF
Publication

A HANSENÍASE E O ITINERÁRIO TERAPÊUTICO NO CONTEXTO DAS CIÊNCIAS SOCIAIS

Pires JCS, Tavares CCSL, Assis JMVD, et al. Atena Editora. Alicerces e Adversidades das Ciências da Saúde no Brasil 5. 2019;
Download PDF
Publication

Factores que determinan el tiempo de mejoría en pacientes con reacción lepromatosa tipo 1

Nova J, Sánchez G, Gil-Quiñones SR. Dermatología Revista mexicana. 2020; 64 (4) : 379-385.
Download PDF
Publication

Typology and pathogenesis of neuropathic pain with leprosy

Belopasov V V. Russian Medical Review. 2018;
Download PDF
Publication

Age, gender and BCG vaccination status as risk factors for Leprosy in endemic areas of northern Brazil.

Lima LNGC, Letícia Pinto Paz J, Silvestre MDPSCA, et al. Research Square. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 372
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD